ES2128471T3 - Agente administrable oralmente que disminuye el colesterol. - Google Patents
Agente administrable oralmente que disminuye el colesterol.Info
- Publication number
- ES2128471T3 ES2128471T3 ES94111996T ES94111996T ES2128471T3 ES 2128471 T3 ES2128471 T3 ES 2128471T3 ES 94111996 T ES94111996 T ES 94111996T ES 94111996 T ES94111996 T ES 94111996T ES 2128471 T3 ES2128471 T3 ES 2128471T3
- Authority
- ES
- Spain
- Prior art keywords
- orally administrable
- weight
- lowering agent
- cholesterol lowering
- hydroxypropylmethylcellulose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 title 2
- 235000012000 cholesterol Nutrition 0.000 title 1
- 239000003529 anticholesteremic agent Substances 0.000 abstract 3
- 229940127226 anticholesterol agent Drugs 0.000 abstract 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 2
- 239000003957 anion exchange resin Substances 0.000 abstract 2
- 239000011248 coating agent Substances 0.000 abstract 2
- 238000000576 coating method Methods 0.000 abstract 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 abstract 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 abstract 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 abstract 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 abstract 2
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 235000012239 silicon dioxide Nutrition 0.000 abstract 1
- 239000000377 silicon dioxide Substances 0.000 abstract 1
- 230000009747 swallowing Effects 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
- A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
SE PROPORCIONA CON UN AGENTE REDUCTOR DEL COLESTEROL, ADMINISTRABLE POR VIA ORAL, QUE SE OBTIENE MEDIANTE REVESTIMIENTO CON TABLETAS PLANAS DE HIDROXIPROPILMETILCELULOSA, CONTENIENDO UNA RESINA DE INTERCAMBIO DE ANIONES COMO UN COMPONENTE ACTIVO, Y CONTENIENDO DEL 14 AL 20% POR PESO DE AGUA, Y NO MAS DEL 2% POR PESO DE DIOXIDO DE SILICIO, BASADO EN EL PESO DE LA RESINA DE INTERCAMBIO DE ANIONES. EL AGENTE REDUCTOR DEL COLESTEROL, ADMINISTRABLE POR VIA ORAL, SE OBTIENE REVISTIENDO LAS TABLETAS MENCIONADAS ANTERIORMENTE CON UNA SOLUCION ACUOSA DE 10-30 CST DE HIDROXIPROPILMETILCELULOSA. ADEMAS DE CARACTERIZARSE POR LA FACILIDAD DE SU DEGLUCION, EL AGENTE REDUCTOR DEL COLESTEROL, ADMINISTRABLE POR VIA ORAL, DE LA PRESENTE INVENCION ES SUPERIOR EN LA CONFIGURABILIDAD DE COMPRESION, ESTABILIDAD EN MEDIO HUMECTADOR Y FLUIDEZ.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP19239293 | 1993-08-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2128471T3 true ES2128471T3 (es) | 1999-05-16 |
Family
ID=16290545
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES94111996T Expired - Lifetime ES2128471T3 (es) | 1993-08-03 | 1994-08-01 | Agente administrable oralmente que disminuye el colesterol. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5447726A (es) |
| EP (1) | EP0637447B1 (es) |
| KR (1) | KR100322340B1 (es) |
| CN (1) | CN1069518C (es) |
| AT (1) | ATE175111T1 (es) |
| CA (1) | CA2129079C (es) |
| DE (1) | DE69415601T2 (es) |
| ES (1) | ES2128471T3 (es) |
| TW (1) | TW349866B (es) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2162658T3 (es) * | 1996-03-05 | 2002-01-01 | Mitsubishi Chem Corp | Utilizacion de resinas intercambiadoras anionicas para la fabricacion de un medicamento destinado al tratamiento de la hiperfosfatemia. |
| US6066336A (en) * | 1997-09-29 | 2000-05-23 | Bristol-Myers Squibb Company | Cholesterol-lowering tablets |
| JP2001115022A (ja) * | 1999-10-18 | 2001-04-24 | Shin Etsu Chem Co Ltd | 室温硬化性オルガノポリシロキサン組成物 |
| US20020054903A1 (en) * | 1999-10-19 | 2002-05-09 | Joseph Tyler | Direct compression polymer tablet core |
| US6733780B1 (en) | 1999-10-19 | 2004-05-11 | Genzyme Corporation | Direct compression polymer tablet core |
| KR100790056B1 (ko) * | 2000-09-06 | 2007-12-31 | 미쯔비시 웰 파마 가부시키가이샤 | 경구용 입제제(粒製劑) |
| JPWO2002043761A1 (ja) * | 2000-11-28 | 2004-04-02 | 三菱ウェルファーマ株式会社 | 抗肥満剤及び健康食品 |
| US20030070584A1 (en) | 2001-05-15 | 2003-04-17 | Cynthia Gulian | Dip coating compositions containing cellulose ethers |
| CA2454732C (en) * | 2001-07-30 | 2010-07-20 | Mitsubishi Pharma Corporation | Drugs for ameliorating postcibal hyperglycemia |
| US8309118B2 (en) | 2001-09-28 | 2012-11-13 | Mcneil-Ppc, Inc. | Film forming compositions containing sucralose |
| US7429619B2 (en) | 2002-08-02 | 2008-09-30 | Mcneil Consumer Healthcare | Polyacrylic film forming compositions |
| US7335795B2 (en) * | 2004-03-22 | 2008-02-26 | Ilypsa, Inc. | Crosslinked amine polymers |
| US7459502B2 (en) * | 2003-11-03 | 2008-12-02 | Ilypsa, Inc. | Pharmaceutical compositions comprising crosslinked polyamine polymers |
| US7449605B2 (en) * | 2003-11-03 | 2008-11-11 | Ilypsa, Inc. | Crosslinked amine polymers |
| US7385012B2 (en) | 2003-11-03 | 2008-06-10 | Ilypsa, Inc. | Polyamine polymers |
| US7608674B2 (en) * | 2003-11-03 | 2009-10-27 | Ilypsa, Inc. | Pharmaceutical compositions comprising cross-linked small molecule amine polymers |
| US7767768B2 (en) * | 2003-11-03 | 2010-08-03 | Ilypsa, Inc. | Crosslinked amine polymers |
| AU2004311849B2 (en) * | 2003-12-31 | 2009-04-02 | Genzyme Corporation | Enteric coated aliphatic amine polymer bile acid sequestrants |
| US20060177415A1 (en) * | 2004-11-01 | 2006-08-10 | Burke Steven K | Once a day formulation for phosphate binders |
| US7985418B2 (en) | 2004-11-01 | 2011-07-26 | Genzyme Corporation | Aliphatic amine polymer salts for tableting |
| JP2009507019A (ja) | 2005-09-02 | 2009-02-19 | ジェンザイム・コーポレーション | リン酸塩を除去する方法およびそれに使用される重合体 |
| WO2007035313A2 (en) | 2005-09-15 | 2007-03-29 | Genzyme Corporation | Sachet formulation for amine polymers |
| WO2008018556A1 (fr) * | 2006-08-09 | 2008-02-14 | Mitsubishi Tanabe Pharma Corporation | Comprimé |
| WO2008042222A2 (en) | 2006-09-29 | 2008-04-10 | Genzyme Corporation | Amide dendrimer compositions |
| EP2120972A1 (en) | 2006-12-14 | 2009-11-25 | Genzyme Corporation | Amido-amine polymer compositions |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS607652B2 (ja) * | 1976-06-12 | 1985-02-26 | 三菱油化株式会社 | 陰イオン交換体の製造法 |
| GB1573487A (en) * | 1977-05-23 | 1980-08-28 | Bristol Myers Co | Bile acid binding composition |
| EP0098884B1 (en) * | 1982-01-18 | 1986-07-23 | Mitsubishi Petrochemical Co., Ltd. | Cholesterol lowering drug |
| JPS60209523A (ja) * | 1984-04-03 | 1985-10-22 | Mitsubishi Petrochem Co Ltd | コレステロ−ル低下剤 |
| US4956182A (en) * | 1989-03-16 | 1990-09-11 | Bristol-Myers Company | Direct compression cholestyramine tablet and solvent-free coating therefor |
| JPH02286621A (ja) * | 1989-04-26 | 1990-11-26 | Mitsubishi Kasei Corp | 経口コレステロール低下剤 |
| CA2071488C (en) * | 1990-08-24 | 1996-05-07 | Kazuto Kobayashi | Base for film-coating pharmaceuticals and method for preparing same |
| US5490987A (en) * | 1991-07-03 | 1996-02-13 | The Upjohn Company | Tableting of colestipol hydrochloride |
| JPH06157325A (ja) * | 1992-11-30 | 1994-06-03 | Mitsubishi Kasei Corp | 経口コレステロール低下剤 |
-
1994
- 1994-07-28 CA CA002129079A patent/CA2129079C/en not_active Expired - Lifetime
- 1994-07-29 US US08/282,553 patent/US5447726A/en not_active Expired - Lifetime
- 1994-08-01 DE DE69415601T patent/DE69415601T2/de not_active Expired - Lifetime
- 1994-08-01 AT AT94111996T patent/ATE175111T1/de not_active IP Right Cessation
- 1994-08-01 ES ES94111996T patent/ES2128471T3/es not_active Expired - Lifetime
- 1994-08-01 EP EP94111996A patent/EP0637447B1/en not_active Expired - Lifetime
- 1994-08-02 TW TW083107074A patent/TW349866B/zh not_active IP Right Cessation
- 1994-08-03 KR KR1019940019207A patent/KR100322340B1/ko not_active Expired - Lifetime
- 1994-08-03 CN CN94108633A patent/CN1069518C/zh not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| KR100322340B1 (ko) | 2002-06-20 |
| US5447726A (en) | 1995-09-05 |
| EP0637447A3 (en) | 1995-05-24 |
| CN1107334A (zh) | 1995-08-30 |
| CN1069518C (zh) | 2001-08-15 |
| CA2129079C (en) | 2006-01-17 |
| ATE175111T1 (de) | 1999-01-15 |
| TW349866B (en) | 1999-01-11 |
| DE69415601T2 (de) | 1999-07-22 |
| CA2129079A1 (en) | 1995-02-04 |
| EP0637447B1 (en) | 1998-12-30 |
| EP0637447A2 (en) | 1995-02-08 |
| DE69415601D1 (de) | 1999-02-11 |
| KR950005316A (ko) | 1995-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2128471T3 (es) | Agente administrable oralmente que disminuye el colesterol. | |
| ES2087425T3 (es) | Agente auxiliar del crespado a base de poliamidas que contienen metil-bis(3-amino-propil)amina. | |
| NO994621L (no) | Ernaeringsformuleringer inneholdende oligosakkarider | |
| YU20197A (sh) | Analozi vitamina d3, farmaceutske kompozicije koje ih sadrže kao aktivnu materiju i njihova upotreba u proizvodnji farmaceutskih kompozicija | |
| GR3024287T3 (en) | Water in oil emulsion for cosmetic or pharmaceutic use. | |
| KR920014465A (ko) | 입욕제 | |
| SE8300736D0 (sv) | Novel pharmacologically active compounds | |
| CA2105088A1 (en) | Liquid soap personal cleanser with critical heat cycle stabilizing system | |
| BRPI0417585A (pt) | composição pregabalina | |
| KR910002426A (ko) | 함수성 외용제 | |
| ATE396743T1 (de) | Stabile elektrolytlösungen enthaltend taurolidin | |
| ATE13765T1 (de) | 2-(1,4-benzodioxan-2-ylalkyl)-imidazole, deren herstellung und sie enthaltende pharmazeutische mittel. | |
| NO911119D0 (no) | Fremgangsmaate for fremstilling av farmasoeytisk jodpreparat | |
| CA2047802A1 (en) | Pharmaceutical compositions | |
| ES2112299T3 (es) | Composiciones detergentes granulares de alta densidad aparente. | |
| ES2154659T3 (es) | Soluciones acuosas de isotiazolin-3-onas estables al almacenamiento. | |
| DE59308567D1 (de) | Tb-wirksame Carbonsäure | |
| ATE127343T1 (de) | Pharmazeutische zubereitung von roxindol oder carmoxirol mit vorgeqüollener stärke. | |
| CA2376121A1 (en) | Stable xylometazoline and oxymetazoline solution | |
| KR910009257A (ko) | 이펜프로딜 및 그의 유도체를 유효성분으로 하는 정신병치료제 | |
| JPS57200361A (en) | "indomethacin(r)" pharmaceutical with low irritant action | |
| GR3023941T3 (en) | Cyclic derivatives of angiopeptin, their preparation and their pharmaceutical compositions. | |
| DK0713485T3 (da) | Thiocarbamoylforbindelser som mikrobicider | |
| ES2049696T3 (es) | Utilizacion de una amida como agente espesante y composicion que la contiene. | |
| FR2703908B1 (fr) | Forme pharmaceutique pour administration rectale de composés pharmacologiquement actifs. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 637447 Country of ref document: ES |